Lv1
50 积分 2026-03-27 加入
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
27天前
已完结
[Efficacy of neoadjuvant therapy on HER2-positive breast cancer: a clinicopathological analysis]
27天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
3个月前
已完结
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
5个月前
已完结
Selective Elimination of Breast Surgery for Invasive Breast Cancer
5个月前
已完结
皖公网安备34019202002308
